Charles Truillet
Researcher and Principal investigator in Orsay, France
Ph.D. in Chemistry with a strong knowledge in biology in signaling pathway, the central aim of my current research is to study novel radiopharmaceuticals or used specific bio-probes designed to measure signaling pathway activity for theranostic applications (Therapy and Diagnostic).
Summary of qualifications:
- Molecular biological studies to assess the interaction mechanism between the radioactive probes and the cells.
- Nuclear Imaging Pre-clinical studies on small animals and protocols assessment.
- Pharmacodynamic studies of treatment.
- Preliminary studies on clinical trials.
- Radioactive probes development and characterization (protein based, material and molecular), for pharmacodynamic noninvasive measurement of the signaling pathways (PI3K/mTOR).
-Analytical chemistry (mass spectrometry, HPLC, TLC, RT PCR, IR, granulometry)